Insider Transactions in Q2 2024 at Pacific Biosciences Of California, Inc. (PACB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2024
|
Hannah Valantine Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+50.0%
|
-
|
|
Jun 18
2024
|
Marshall Mohr Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+14.66%
|
-
|
|
Jun 18
2024
|
Kathy Ordonez Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+5.36%
|
-
|
|
Jun 18
2024
|
Lucy Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+50.0%
|
-
|
|
Jun 18
2024
|
David W Meline Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,116
+23.06%
|
-
|
|
Jun 18
2024
|
John F Milligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+14.66%
|
-
|
|
Jun 18
2024
|
William W. Ericson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+35.42%
|
-
|
|
Jun 18
2024
|
Randall S Livingston Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,821
+50.0%
|
-
|
|
May 20
2024
|
Michele Farmer Officer |
SELL
Open market or private sale
|
Direct |
5,275
-2.43%
|
$10,550
$2.03 P/Share
|